OBM Transplantation is an international peer-reviewed Open Access journal, which covers all evidence-based scientific studies related to transplantation, including: transplantation procedures and the maintenance of transplanted tissues or organs; assimilation of grafted tissue and the reconstitution of removed organs or parts of organs; transplantation of heart, lung, kidney, liver, pancreatic islets and bone marrow, etc. Areas related to clinical and experimental transplantation are also of interest.
OBM Transplantation is committed to rapid review and publication, and we aim at serving the international transplant community with high accessibility as well as relevant and high quality content.
We welcome original clinical studies as well as basic science, reviews, short reports/rapid communications, case reports, opinions, technical notes, book reviews as well as letters to the editor.
Archiving: full-text archived in CLOCKSS.
Rapid publication: manuscripts are undertaken in 8 days from acceptance to publication (median values for papers published in this journal in 2021, 1-2 days of FREE language polishing time is also included in this period).
Novel Cellular Therapies in Hemato-Oncology
Submission Deadline: April 30, 2021 (Open) Submit Now
Thomas Pabst, M.D
Associate Professor, Director Clinical Trial Unit and Medical Director Stem Cell Program Clinic Adults, Department of Medical Oncology, University Hospital/Inselspital, 3010 Bern, Switzerland
Tel: +41 31 632 84 30
Fax: +41 31 632 34 10
Research Interests: Hemato-oncology; acute myeloid leukemia (AML); stem cell; CEBPA; GATA2; acute and chronic leukemia; graft-versus-leukemia; autologous stem cell transplantation; allogeneic stem cell transplantation
To prevent robots and page crawlers from submitting fraudulent forms, complete verification to prove that you are a human.